Insider Trading History of Sundaram Senthil Vel

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Sundaram Senthil Vel since 2019. This trader's CIK number is 1762316. At the time of last reporting, Sundaram Senthil Vel was the Chief Executive Officer of Terns Pharmaceuticals, Inc.. (stock ticker symbol TERN). Also see all insider trading activities at Terns Pharmaceuticals, Inc..

Note that in the past Sundaram Senthil Vel also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Terns Pharmaceuticals, Inc. (TERN) by Sundaram Senthil Vel

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 TERN 4,225 $5,956 0 $0 0 $0
2022 TERN 7,656 $11,254 0 $0 0 $0

Yearly summary of insider trading at Nightstar Therapeutics Plc (NITE) by Sundaram Senthil Vel

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 NITE 0 $0 797 $15,166 0 $0


Insider trading activities at 2 companies by Sundaram Senthil Vel:

1. Terns Pharmaceuticals, Inc. (TERN)

2. Nightstar Therapeutics Plc (NITE)

Table 1. Insider trading of Terns Pharmaceuticals, Inc. (TERN) by Sundaram Senthil Vel

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-05-31 TERN Buy 2,111 1.41 2,976
2023-05-31 TERN Buy 2,111 1.41 2,976
2022-11-30 TERN Buy 3 1.41 4
2022-05-31 TERN Buy 7,656 1.47 11,254

Table 2. Insider trading of Nightstar Therapeutics Plc (NITE) by Sundaram Senthil Vel

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-04-01 NITE Sale 391 25.31 9,896
2019-01-07 NITE Sale 406 12.98 5,270

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sundaram Senthil Vel (Chief Executive Officer of Terns Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.